Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Concomitant Anticoagulant and Antidepressant Therapy in Atrial Fibrillation Patients and Risk of Stroke and Bleeding.

Komen JJ, Hjemdahl P, Mantel-Teeuwisse AK, Klungel OH, Wettermark B, Forslund T.

Clin Pharmacol Ther. 2019 Sep 10. doi: 10.1002/cpt.1603. [Epub ahead of print]

PMID:
31506933
2.

Risk of Nephrotic Syndrome for Non-Steroidal Anti-Inflammatory Drug Users.

Bakhriansyah M, Souverein PC, van den Hoogen MWF, de Boer A, Klungel OH.

Clin J Am Soc Nephrol. 2019 Sep 6;14(9):1355-1362. doi: 10.2215/CJN.14331218. Epub 2019 Aug 15.

PMID:
31416888
3.

Amiodarone use and the risk of acute pancreatitis: Influence of different exposure definitions.

Hempenius M, Groenwold RHH, de Boer A, Klungel OH, Gardarsdottir H.

Pharmacoepidemiol Drug Saf. 2019 Aug 2. doi: 10.1002/pds.4851. [Epub ahead of print]

PMID:
31373736
4.

Risk of myocardial infarction associated with non-steroidal anti-inflammatory drugs: Impact of additional confounding control for variables collected from self-reported data.

Bakhriansyah M, Souverein PC, de Boer A, Klungel OH.

J Clin Pharm Ther. 2019 Aug;44(4):623-631. doi: 10.1111/jcpt.12836. Epub 2019 Apr 7.

PMID:
30957267
5.

Accuracy of budget impact estimations and impact on patient access: a hepatitis C case study.

Geenen JW, Boersma C, Klungel OH, Hövels AM.

Eur J Health Econ. 2019 Aug;20(6):857-867. doi: 10.1007/s10198-019-01048-z. Epub 2019 Apr 5.

6.

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events.

Patel RS, Schmidt AF, Tragante V, McCubrey RO, Holmes MV, Howe LJ, Direk K, Åkerblom A, Leander K, Virani SS, Kaminski KA, Muehlschlegel JD, Dubé MP, Allayee H, Almgren P, Alver M, Baranova EV, Behlouli H, Boeckx B, Braund PS, Breitling LP, Delgado G, Duarte NE, Dufresne L, Eriksson N, Foco L, Gijsberts CM, Gong Y, Hartiala J, Heydarpour M, Hubacek JA, Kleber M, Kofink D, Kuukasjärvi P, Lee VV, Leiherer A, Lenzini PA, Levin D, Lyytikäinen LP, Martinelli N, Mons U, Nelson CP, Nikus K, Pilbrow AP, Ploski R, Sun YV, Tanck MWT, Tang WHW, Trompet S, van der Laan SW, van Setten J, Vilmundarson RO, Viviani Anselmi C, Vlachopoulou E, Boerwinkle E, Briguori C, Carlquist JF, Carruthers KF, Casu G, Deanfield J, Deloukas P, Dudbridge F, Fitzpatrick N, Gigante B, James S, Lokki ML, Lotufo PA, Marziliano N, Mordi IR, Muhlestein JB, Newton Cheh C, Pitha J, Saely CH, Samman-Tahhan A, Sandesara PB, Teren A, Timmis A, Van de Werf F, Wauters E, Wilde AAM, Ford I, Stott DJ, Algra A, Andreassi MG, Ardissino D, Arsenault BJ, Ballantyne CM, Bergmeijer TO, Bezzina CR, Body SC, Bogaty P, de Borst GJ, Brenner H, Burkhardt R, Carpeggiani C, Condorelli G, Cooper-DeHoff RM, Cresci S, de Faire U, Doughty RN, Drexel H, Engert JC, Fox KAA, Girelli D, Hagström E, Hazen SL, Held C, Hemingway H, Hoefer IE, Hovingh GK, Johnson JA, de Jong PA, Jukema JW, Kaczor MP, Kähönen M, Kettner J, Kiliszek M, Klungel OH, Lagerqvist B, Lambrechts D, Laurikka JO, Lehtimäki T, Lindholm D, Mahmoodi BK, Maitland-van der Zee AH, McPherson R, Melander O, Metspalu A, Pepinski W, Olivieri O, Opolski G, Palmer CN, Pasterkamp G, Pepine CJ, Pereira AC, Pilote L, Quyyumi AA, Richards AM, Sanak M, Scholz M, Siegbahn A, Sinisalo J, Smith JG, Spertus JA, Stewart AFR, Szczeklik W, Szpakowicz A, Ten Berg JM, Thanassoulis G, Thiery J, van der Graaf Y, Visseren FLJ, Waltenberger J; CARDIoGRAMPlusC4D Consortium, Van der Harst P, Tardif JC, Sattar N, Lang CC, Pare G, Brophy JM, Anderson JL, März W, Wallentin L, Cameron VA, Horne BD, Samani NJ, Hingorani AD, Asselbergs FW.

Circ Genom Precis Med. 2019 Apr;12(4):e002471. doi: 10.1161/CIRCGEN.119.002471. Epub 2019 Mar 21.

PMID:
30897348
7.

Subsequent Event Risk in Individuals With Established Coronary Heart Disease.

Patel RS, Tragante V, Schmidt AF, McCubrey RO, Holmes MV, Howe LJ, Direk K, Åkerblom A, Leander K, Virani SS, Kaminski KA, Muehlschlegel JD, Allayee H, Almgren P, Alver M, Baranova EV, Behloui H, Boeckx B, Braund PS, Breitling LP, Delgado G, Duarte NE, Dubé MP, Dufresne L, Eriksson N, Foco L, Scholz M, Gijsberts CM, Glinge C, Gong Y, Hartiala J, Heydarpour M, Hubacek JA, Kleber M, Kofink D, Kotti S, Kuukasjärvi P, Lee VV, Leiherer A, Lenzini PA, Levin D, Lyytikäinen LP, Martinelli N, Mons U, Nelson CP, Nikus K, Pilbrow AP, Ploski R, Sun YV, Tanck MWT, Tang WHW, Trompet S, van der Laan SW, Van Setten J, Vilmundarson RO, Viviani Anselmi C, Vlachopoulou E, Al Ali L, Boerwinkle E, Briguori C, Carlquist JF, Carruthers KF, Casu G, Deanfield J, Deloukas P, Dudbridge F, Engstrøm T, Fitzpatrick N, Fox K, Gigante B, James S, Lokki ML, Lotufo PA, Marziliano N, Mordi IR, Muhlestein JB, Newton-Cheh C, Pitha J, Saely CH, Samman-Tahhan A, Sandesara PB, Teren A, Timmis A, Van de Werf F, Wauters E, Wilde AAM, Ford I, Stott DJ, Algra A, Andreassi MG, Ardissino D, Arsenault BJ, Ballantyne CM, Bergmeijer TO, Bezzina CR, Body SC, Boersma EH, Bogaty P, Bots ML, Brenner H, Brugts JJ, Burkhardt R, Carpeggiani C, Condorelli G, Cooper-DeHoff RM, Cresci S, Danchin N, de Faire U, Doughty RN, Drexel H, Engert JC, Fox KAA, Girelli D, Grobbee DE, Hagström E, Hazen SL, Held C, Hemingway H, Hoefer IE, Hovingh GK, Jabbari R, Johnson JA, Jukema JW, Kaczor MP, Kähönen M, Kettner J, Kiliszek M, Klungel OH, Lagerqvist B, Lambrechts D, Laurikka JO, Lehtimäki T, Lindholm D, Mahmoodi BK, Maitland-van der Zee AH, McPherson R, Melander O, Metspalu A, Niemcunowicz-Janica A, Olivieri O, Opolski G, Palmer CN, Pasterkamp G, Pepine CJ, Pereira AC, Pilote L, Quyyumi AA, Richards AM, Sanak M, Siegbahn A, Simon T, Sinisalo J, Smith JG, Spertus JA, Stender S, Stewart AFR, Szczeklik W, Szpakowicz A, Tardif JC, Ten Berg JM, Tfelt-Hansen J, Thanassoulis G, Thiery J, Torp-Pedersen C, van der Graaf Y, Visseren FLJ, Waltenberger J, Weeke PE, Van der Harst P, Lang CC, Sattar N, Cameron VA, Anderson JL, Brophy JM, Pare G, Horne BD, März W, Wallentin L, Samani NJ, Hingorani AD, Asselbergs FW.

Circ Genom Precis Med. 2019 Apr;12(4):e002470. doi: 10.1161/CIRCGEN.119.002470. Epub 2019 Mar 21.

PMID:
30896328
8.

Cyclo-oxygenase selectivity and chemical groups of nonsteroidal anti-inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/noncase study in VigiBase.

Bakhriansyah M, Meyboom RHB, Souverein PC, de Boer A, Klungel OH.

Fundam Clin Pharmacol. 2019 Oct;33(5):589-600. doi: 10.1111/fcp.12463. Epub 2019 Apr 22.

PMID:
30860620
9.

How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias.

Platt RW, Platt R, Brown JS, Henry DA, Klungel OH, Suissa S.

Pharmacoepidemiol Drug Saf. 2019 Jan 15. doi: 10.1002/pds.4722. [Epub ahead of print]

PMID:
30648307
10.

Social media as a tool for assessing patient perspectives on quality of life in metastatic melanoma: a feasibility study.

Makady A, Kalf RRJ, Ryll B, Spurrier G, de Boer A, Hillege H, Klungel OH, Goettsch W; GetReal Workpackage 1.

Health Qual Life Outcomes. 2018 Nov 29;16(1):222. doi: 10.1186/s12955-018-1047-z.

11.

Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer.

Cramer-van der Welle CM, Peters BJM, Schramel FMNH, Klungel OH, Groen HJM, van de Garde EMW; Santeon NSCLC Study Group; Santeon NSCLC study group.

Eur Respir J. 2018 Dec 20;52(6). pii: 1801100. doi: 10.1183/13993003.01100-2018. Print 2018 Dec.

12.

Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe.

Ten Ham RMT, Hoekman J, Hövels AM, Broekmans AW, Leufkens HGM, Klungel OH.

Mol Ther Methods Clin Dev. 2018 Oct 11;11:121-130. doi: 10.1016/j.omtm.2018.10.003. eCollection 2018 Dec 14.

13.

Implementing managed entry agreements in practice: The Dutch reality check.

Makady A, van Veelen A, de Boer A, Hillege H, Klungel OH, Goettsch W.

Health Policy. 2019 Mar;123(3):267-274. doi: 10.1016/j.healthpol.2018.09.016. Epub 2018 Sep 28.

PMID:
30316540
14.

Non-steroidal anti-inflammatory drugs and the risk of out-of-hospital cardiac arrest: a case-control study.

Bakhriansyah M, Souverein PC, Klungel OH, de Boer A, Blom MT, Tan HL.

Europace. 2019 Jan 1;21(1):99-105. doi: 10.1093/europace/euy180. Erratum in: Europace. 2019 Jan 1;21(1):105.

15.

Using a single noninferiority margin or preserved fraction for an entire pharmacological class was found to be inappropriate.

Althunian TA, de Boer A, Groenwold RHH, Klungel OH.

J Clin Epidemiol. 2018 Dec;104:15-23. doi: 10.1016/j.jclinepi.2018.07.004. Epub 2018 Aug 25.

PMID:
30009941
16.

Postauthorization Changes to Specific Obligations of Conditionally Authorized Medicines in the European Union: A Retrospective Cohort Study.

Bloem LT, Mantel-Teeuwisse AK, Leufkens HGM, De Bruin ML, Klungel OH, Hoekman J.

Clin Pharmacol Ther. 2019 Feb;105(2):426-435. doi: 10.1002/cpt.1169. Epub 2018 Aug 12.

PMID:
29969839
17.

Exploring the role of low-frequency and rare exonic variants in alcohol and tobacco use.

Marees AT, Hammerschlag AR, Bastarache L, de Kluiver H, Vorspan F, van den Brink W, Smit DJ, Denys D, Gamazon ER, Li-Gao R, Breetvelt EJ, de Groot MCH, Galesloot TE, Vermeulen SH, Poppelaars JL, Souverein PC, Keeman R, de Mutsert R, Noordam R, Rosendaal FR, Stringa N, Mook-Kanamori DO, Vaartjes I, Kiemeney LA, den Heijer M, van Schoor NM, Klungel OH, Maitland-Van der Zee AH, Schmidt MK, Polderman TJC, van der Leij AR, Posthuma D, Derks EM.

Drug Alcohol Depend. 2018 Jul 1;188:94-101. doi: 10.1016/j.drugalcdep.2018.03.026. Epub 2018 Apr 25.

18.

Pattern of risks of rheumatoid arthritis among patients using statins: A cohort study with the clinical practice research datalink.

de Jong HJI, Cohen Tervaert JW, Lalmohamed A, de Vries F, Vandebriel RJ, van Loveren H, Klungel OH, van Staa TP.

PLoS One. 2018 Feb 23;13(2):e0193297. doi: 10.1371/journal.pone.0193297. eCollection 2018.

19.

Risk of a first-ever acute myocardial infarction and all-cause mortality with sulphonylurea treatment: A population-based cohort study.

van Dalem J, Brouwers MCGJ, Stehouwer CDA, Krings A, Klungel OH, Driessen JHM, de Vries F, Burden AM.

Diabetes Obes Metab. 2018 Apr;20(4):1056-1060. doi: 10.1111/dom.13168. Epub 2017 Dec 27.

20.

Patients' beliefs about medicine are associated with early thiopurine discontinuation in patients with inflammatory bowel diseases.

Broekman MMTJ, Coenen MJH, Wanten GJ, van Marrewijk CJ, Kievit W, Klungel OH, Verbeek ALM, Wong DR, Hooymans PM, Guchelaar HJ, Scheffer H, Derijks LJJ, Bouvy ML, de Jong DJ.

Eur J Gastroenterol Hepatol. 2018 Feb;30(2):167-173. doi: 10.1097/MEG.0000000000001025.

21.

Risk factors for thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype.

Broekman MMTJ, Coenen MJH, Wanten GJ, van Marrewijk CJ, Klungel OH, Verbeek ALM, Hooymans PM, Guchelaar HJ, Scheffer H, Derijks LJJ, Wong DR, de Jong DJ.

Aliment Pharmacol Ther. 2017 Nov;46(10):953-963. doi: 10.1111/apt.14323. Epub 2017 Sep 15.

22.

Medications Recommended for Secondary Prevention After First Acute Coronary Syndrome: Effectiveness of Treatment Combinations in a Real-Life Setting.

Bezin J, Klungel OH, Lassalle R, Dureau-Pournin C, Moore N, Pariente A.

Clin Pharmacol Ther. 2018 Jun;103(6):1038-1046. doi: 10.1002/cpt.864. Epub 2017 Sep 28.

PMID:
28875506
23.

Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study.

Wing K, Bhaskaran K, Pealing L, Root A, Smeeth L, van Staa TP, Klungel OH, Reynolds RF, Douglas I.

J Antimicrob Chemother. 2017 Sep 1;72(9):2636-2646. doi: 10.1093/jac/dkx183.

24.

The impact of age and sex on the reporting of cough and angioedema with renin-angiotensin system inhibitors: a case/noncase study in VigiBase.

Alharbi FF, Kholod AAV, Souverein PC, Meyboom RH, de Groot MCH, de Boer A, Klungel OH.

Fundam Clin Pharmacol. 2017 Dec;31(6):676-684. doi: 10.1111/fcp.12313. Epub 2017 Sep 5.

PMID:
28767167
25.

Pattern of risks of systemic lupus erythematosus among statin users: a population-based cohort study.

De Jong HJI, van Staa TP, Lalmohamed A, de Vries F, Vandebriel RJ, Van Loveren H, Klungel OH, Cohen Tervaert JW.

Ann Rheum Dis. 2017 Oct;76(10):1723-1730. doi: 10.1136/annrheumdis-2016-210936. Epub 2017 Jul 6.

PMID:
28684558
26.

The impact of serum potassium-influencing antihypertensive drugs on the risk of out-of-hospital cardiac arrest: A case-control study.

Alharbi FF, Souverein PC, de Groot MCH, Blom MT, de Boer A, Klungel OH, Tan HL.

Br J Clin Pharmacol. 2017 Nov;83(11):2541-2548. doi: 10.1111/bcp.13356. Epub 2017 Aug 16.

27.

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing.

Broekman MMTJ, Coenen MJH, van Marrewijk CJ, Wanten GJA, Wong DR, Verbeek ALM, Klungel OH, Hooymans PM, Guchelaar HJ, Scheffer H, Derijks LJJ, de Jong DJ; TOPIC Recruitment Team.

Inflamm Bowel Dis. 2017 Oct;23(10):1873-1881. doi: 10.1097/MIB.0000000000001163.

28.

Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control study.

Bakhriansyah M, Souverein PC, de Boer A, Klungel OH.

Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1141-1148. doi: 10.1002/pds.4183. Epub 2017 Mar 31.

29.

Risk of acute myocardial infarction after discontinuation of antihypertensive agents: a case-control study.

Alharbi FF, Souverein PC, de Groot MC, Maitland-van der Zee AH, de Boer A, Klungel OH.

J Hum Hypertens. 2017 Aug;31(8):537-544. doi: 10.1038/jhh.2017.1. Epub 2017 Mar 23.

PMID:
28332511
30.

Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review.

Althunian TA, de Boer A, Klungel OH, Insani WN, Groenwold RH.

Trials. 2017 Mar 7;18(1):107. doi: 10.1186/s13063-017-1859-x. Review.

31.

Defining the noninferiority margin and analysing noninferiority: An overview.

Althunian TA, de Boer A, Groenwold RHH, Klungel OH.

Br J Clin Pharmacol. 2017 Aug;83(8):1636-1642. doi: 10.1111/bcp.13280. Epub 2017 Apr 6.

32.

A systematic literature review on the efficacy-effectiveness gap: comparison of randomized controlled trials and observational studies of glucose-lowering drugs.

Ankarfeldt MZ, Adalsteinsson E, Groenwold RH, Ali MS, Klungel OH.

Clin Epidemiol. 2017 Jan 23;9:41-51. doi: 10.2147/CLEP.S121991. eCollection 2017. Review.

33.

Assessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study.

Ankarfeldt MZ, Thorsted BL, Groenwold RH, Adalsteinsson E, Ali MS, Klungel OH.

Clin Epidemiol. 2017 Jan 18;9:19-30. doi: 10.2147/CLEP.S124054. eCollection 2017. Erratum in: Clin Epidemiol. 2018 Nov 28;10:1787.

34.

Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndrome.

Bezin J, Groenwold RH, Ali MS, Lassalle R, Robinson P, de Boer A, Moore N, Klungel OH, Pariente A.

Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):285-293. doi: 10.1002/pds.4171. Epub 2017 Jan 26.

PMID:
28124399
35.

The glutathione transferase Mu null genotype leads to lower 6-MMPR levels in patients treated with azathioprine but not with mercaptopurine.

Broekman MMTJ, Wong DR, Wanten GJA, Roelofs HM, van Marrewijk CJ, Klungel OH, Verbeek ALM, Hooymans PM, Guchelaar HJ, Scheffer H, Derijks LJJ, Coenen MJH, de Jong DJ.

Pharmacogenomics J. 2018 Jan;18(1):160-166. doi: 10.1038/tpj.2016.87. Epub 2017 Jan 3.

PMID:
28045129
36.

Early prediction of thiopurine-induced hepatotoxicity in inflammatory bowel disease.

Wong DR, Coenen MJ, Derijks LJ, Vermeulen SH, van Marrewijk CJ, Klungel OH, Scheffer H, Franke B, Guchelaar HJ, de Jong DJ, Engels LG, Verbeek AL, Hooymans PM; TOPIC Recruitment Team.

Aliment Pharmacol Ther. 2017 Feb;45(3):391-402. doi: 10.1111/apt.13879. Epub 2016 Dec 12.

37.

Patterns of antiplatelet drug use after a first myocardial infarction during a 10-year period.

Yasmina A, de Boer A, Deneer VH, Souverein PC, Klungel OH.

Br J Clin Pharmacol. 2017 Mar;83(3):632-641. doi: 10.1111/bcp.13139. Epub 2016 Oct 24.

38.

Optimising case detection within UK electronic health records: use of multiple linked databases for detecting liver injury.

Wing K, Bhaskaran K, Smeeth L, van Staa TP, Klungel OH, Reynolds RF, Douglas I.

BMJ Open. 2016 Sep 2;6(9):e012102. doi: 10.1136/bmjopen-2016-012102.

39.

Best (but oft-forgotten) practices: propensity score methods in clinical nutrition research.

Ali MS, Groenwold RH, Klungel OH.

Am J Clin Nutr. 2016 Aug;104(2):247-58. doi: 10.3945/ajcn.115.125914. Epub 2016 Jul 13.

PMID:
27413128
40.

Early Assessment of Thiopurine Metabolites Identifies Patients at Risk of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease.

Wong DR, Coenen MJ, Vermeulen SH, Derijks LJ, van Marrewijk CJ, Klungel OH, Scheffer H, Franke B, Guchelaar HJ, de Jong DJ, Engels LG, Verbeek AL, Hooymans PM; TOPIC recruitment team.

J Crohns Colitis. 2017 Feb;11(2):175-184. doi: 10.1093/ecco-jcc/jjw130. Epub 2016 Jul 9.

PMID:
27402913
41.

Reply: Comparing the ATRIA, CHADS2, and CHA2DS2-VASc Scores for Stroke Prediction in Atrial Fibrillation.

van den Ham HA, Klungel OH, Singer DE, Leufkens HGM, van Staa TP.

J Am Coll Cardiol. 2016 May 17;67(19):2317-2318. doi: 10.1016/j.jacc.2016.01.085. No abstract available.

42.

Methods to control for unmeasured confounding in pharmacoepidemiology: an overview.

Uddin MJ, Groenwold RH, Ali MS, de Boer A, Roes KC, Chowdhury MA, Klungel OH.

Int J Clin Pharm. 2016 Jun;38(3):714-23. doi: 10.1007/s11096-016-0299-0. Epub 2016 Apr 18. Review.

PMID:
27091131
43.

Multi-centre, multi-database studies with common protocols: lessons learnt from the IMI PROTECT project.

Klungel OH, Kurz X, de Groot MC, Schlienger RG, Tcherny-Lessenot S, Grimaldi L, Ibáñez L, Groenwold RH, Reynolds RF.

Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:156-65. doi: 10.1002/pds.3968.

PMID:
27038361
44.

Evaluating different physician's prescribing preference based instrumental variables in two primary care databases: a study of inhaled long-acting beta2-agonist use and the risk of myocardial infarction.

Uddin MJ, Groenwold RH, de Boer A, Afonso AS, Primatesta P, Becker C, Belitser SV, Hoes AW, Roes KC, Klungel OH.

Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:132-41. doi: 10.1002/pds.3860.

PMID:
27038359
45.

Instrumental variables analysis using multiple databases: an example of antidepressant use and risk of hip fracture.

Uddin MJ, Groenwold RH, de Boer A, Gardarsdottir H, Martin E, Candore G, Belitser SV, Hoes AW, Roes KC, Klungel OH.

Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:122-31. doi: 10.1002/pds.3863.

PMID:
27038358
46.

Methodological comparison of marginal structural model, time-varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fracture.

Ali MS, Groenwold RH, Belitser SV, Souverein PC, Martín E, Gatto NM, Huerta C, Gardarsdottir H, Roes KC, Hoes AW, de Boer A, Klungel OH.

Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:114-21. doi: 10.1002/pds.3864.

PMID:
27038357
47.

Case-only designs for studying the association of antidepressants and hip or femur fracture.

de Groot MC, Candore G, Uddin MJ, Souverein PC, Ali MS, Belitser SV, Huerta C, Groenwold RH, Alvarez Y, Slattery J, Korevaar J, Hoes AW, Roes KC, de Boer A, Douglas IJ, Schlienger RG, Reynolds R, Klungel OH, Gardarsdottir H.

Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:103-13. doi: 10.1002/pds.3850.

48.

Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures.

Souverein PC, Abbing-Karahagopian V, Martin E, Huerta C, de Abajo F, Leufkens HG, Candore G, Alvarez Y, Slattery J, Miret M, Requena G, Gil MJ, Groenwold RH, Reynolds R, Schlienger RG, Logie JW, de Groot MC, Klungel OH, van Staa TP, Egberts TC, De Bruin ML, Gardarsdottir H.

Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:88-102. doi: 10.1002/pds.3862.

PMID:
27038355
49.

The IMI PROTECT project: purpose, organizational structure, and procedures.

Reynolds RF, Kurz X, de Groot MC, Schlienger RG, Grimaldi-Bensouda L, Tcherny-Lessenot S, Klungel OH.

Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:5-10. doi: 10.1002/pds.3933.

PMID:
27038353
50.

Tailoring treatments using treatment effect modification.

Schmidt AF, Klungel OH, Nielen M, de Boer A, Groenwold RH, Hoes AW.

Pharmacoepidemiol Drug Saf. 2016 Apr;25(4):355-62. doi: 10.1002/pds.3965. Epub 2016 Feb 15. Review.

PMID:
26877168

Supplemental Content

Loading ...
Support Center